期刊文献+

调节性T细胞在肿瘤免疫和肿瘤免疫治疗中的作用 被引量:51

Roles of regulatory T cell in tumor immunity and tumor immunotherapy
下载PDF
导出
摘要 肿瘤局部存在多种类型的免疫抑制性细胞,其中调节性T细胞(regulatoryT cell,Treg)在肿瘤的发生、发展过程中发挥着极为重要的作用。Treg通过多种机制抑制免疫效应细胞的功能,是肿瘤免疫逃逸的关键因素。这些机制包括分泌抑制性细胞因子抑制效应细胞功能、分泌颗粒酶和穿孔素杀伤效应细胞、干扰效应细胞的代谢功能,以及通过调控树突状细胞影响Treg的分化和增殖,等等。Treg的深入研究为肿瘤免疫治疗提供了新的思路,以Treg及相关免疫抑制性分子作为靶点,通过特异性或非特异性清除Treg、控制Treg的数量和功能等开展肿瘤免疫治疗具有良好的临床应用前景。 There are multiple types of inhibitory immune cells in tumor.Among these cells,Treg (regulatory T cell) plays an extremely important role in tumor development and progression.Treg exihibits potent inhibitory effects on effector cells by a variety of mechanisms,which might be the the key factor for tumor immune escape.These mechanisms include inhibiting the effector cell function by inhibitory cytokines,killing effector cells by granzyme and profrin,interfering effector cell metabolism,and affecting Treg differentiation and proliferation by regulating the function of dendrtic cells,etc.The research on Treg has provided new strategies for tumor immunotherapy.Tumor immunotherapies targeting Treg and related immunosuppressive factors,such as deleting Treg non-sepcificlly or sepcificlly controling the numbers and functions of Treg,might have a bright future in clinical application.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第1期1-6,共6页 Chinese Journal of Cancer Biotherapy
基金 国家重点基础研究发展规划(973计划)资助项目(No.2010CB529901) 卫生部重大传染病防治科技重大专项(No.008ZX10002-008)~~
关键词 调节性T细胞 肿瘤 免疫逃逸 免疫治疗 regulatory T cell(Treg) neoplasms immune escape immunotherapy
  • 相关文献

参考文献65

  • 1Gershon RK, Kondo K. Infectious immunological tolerance [J]. Immunology, 1971 , 21 (6) : 903-914.
  • 2Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes [ J ]. Immunology, 1970, 18 ( 5 ) : 723-737.
  • 3Fujimoto S, Greene M, Sehon AH. Immunosuppressor T cells in tumor bearing host [J]. Immunol Commun, 1975, 4(3):201- 217.
  • 4Berendt MJ, North RJ. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenie tumor [J]. J Exp Med, 1980, 151 ( 1 ) : 69-80.
  • 5Bursuker I, North RJ. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity [J]. J Exp Med, 1984, 159(5) : 1312-1321.
  • 6North R J, Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I Ly-1-2- suppressor T ceils down-regulate the generation of Ly-1-2 + effector T cells [ J 1. J Exp Med, 1984, 159(5) : 1295-1311.
  • 7Chakraborty NG, Twardzik DR, Sivanandham M, Ergin MT, Hellstrom KE, Mukherji B. Autologous melanoma-induced activation of regulatory T ceils that suppress cytotoxic response [ J ]. J Immunol, 1990, 145(7) : 2359-2364.
  • 8Sakaguchi S, Sakaguehi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [ J]. J Immunol, 1995, 155(3): 1151-1164.
  • 9Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 ( interleukin-2 receptor alpha) monoclonal antibody [ J ]. Cancer Res, 1999, 59(13): 3128-3133.
  • 10Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25 + CD4 + T cells : a common basis between tumor immunity and autoimmunity [ J]. J Immunol, 1999, 163 (10): 5211-5218.

同被引文献560

引证文献51

二级引证文献410

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部